Askarian M, Assadian O, Safaee GhR, Golkar A, Namazi S, Movahed M R
Department of Community Medicine, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran.
East Mediterr Health J. 2007 Sep-Oct;13(5):1195-201. doi: 10.26719/2007.13.5.1195.
We investigated adherence to the Hospital Infection Control Practice Advisory Committee (HICPAC) guidelines on vancomycin prescription in a large university-affiliated hospital in Shiraz. From August to December 2003, 200 hospitalized patients received vancomycin. For only 12 (6%) of these patients was vancomycin prescribed appropriately according to HICPAC guidelines. The main reasons why vancomycin use did not comply with HICPAC recommendations were: surgical prophylaxis in patients with negative cultures for resistant Gram-positive organisms, no investigation of vancomycin serum levels in patients receiving > 48 hours of vancomycin, vancomycin serum levels not repeated in patients receiving > 1 week of vancomycin, no appropriate adjustment of dosage with respect to serum levels in patients receiving vancomycin.
我们在设拉子一所大型大学附属医院调查了对医院感染控制实践咨询委员会(HICPAC)万古霉素处方指南的遵循情况。2003年8月至12月期间,200名住院患者接受了万古霉素治疗。根据HICPAC指南,这些患者中只有12名(6%)万古霉素的处方是恰当的。万古霉素使用不符合HICPAC建议的主要原因是:对革兰氏阳性耐药菌培养阴性的患者进行手术预防,接受万古霉素治疗超过48小时的患者未检测万古霉素血清水平,接受万古霉素治疗超过1周的患者未重复检测万古霉素血清水平,接受万古霉素治疗的患者未根据血清水平适当调整剂量。